Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preparing Psychiatric Residents for Workplace Violence: Evaluating the Impact of Self-Defense and Situational Awareness Training.

Journal of healthcare management / American College of Healthcare Executives·2026
Same author

Impact of Preterm Birth Subtype on Risk of Diagnosis of Autism Spectrum Disorders in the Offspring.

Journal of autism and developmental disorders·2025
Same author

Postpartum Depression Increases the Risk of Autism Diagnosis in the Offspring.

JAACAP open·2025
Same author

Postpartum Depression Increases the Risk of Childhood Attention Deficit Hyperactivity Disorder Diagnosis.

Reproductive sciences (Thousand Oaks, Calif.)·2025
Same author

Joint Effect of Body Mass Index and Obstructive Sleep Apnea on Preeclampsia Risk.

American journal of perinatology·2025
Same author

Recurrence Risk of Preterm Birth in Successive Pregnancies Based on Its Subtypes.

American journal of perinatology·2025

Related Experiment Video

Updated: Jun 3, 2025

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.2K

Algorithm-informed treatment from EEG patterns improves outcomes for patients with major depressive disorder.

Ramon Solhkhah1,2,3,4, Justin Feintuch5, Mabel Vasquez5

  • 1Department of Psychiatry and Behavioral Science, Endeavor Health Northshore and Swedish Hospitals, Evanston, IL, USA.

Journal of Family Medicine and Primary Care
|January 10, 2025
PubMed
Summary

Computer-guided medication selection using electroencephalogram (EEG) patterns improved outcomes for major depressive disorder (MDD) patients. Following the EEG report fully (RF/RF) showed significantly stronger symptom reduction and lower suicidal ideation rates compared to standard care.

Keywords:
Computer-assisted treatmentEEGdepressionmedication

More Related Videos

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.5K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.8K

Related Experiment Videos

Last Updated: Jun 3, 2025

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.2K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.5K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.8K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Computational Biology

Background:

  • Selecting effective medications for major depressive disorder (MDD) is a significant clinical challenge.
  • Current treatment selection relies heavily on physician judgment, often leading to trial-and-error approaches.
  • Electroencephalogram (EEG) patterns offer a potential biomarker for guiding personalized MDD treatment.

Purpose of the Study:

  • To evaluate a commercially available EEG data analysis system for guiding medication selection in MDD patients.
  • To compare clinical outcomes between patients receiving standard care versus computer-guided treatment selection.

Main Methods:

  • A prospective study involving MDD patients randomized to physician judgment (Control, n=115) or computer-guided selection (PEER, n=165).
  • Physicians used their judgment or followed PEER system recommendations for medication selection.
  • Depressive symptoms (QIDS SR-16) and suicidal ideation were assessed at baseline, 90, and 180 days.

Main Results:

  • Patients in the PEER group who fully followed the EEG report (RF/RF) showed significantly greater reduction in depressive symptoms at 90 and 180 days compared to controls.
  • The RF/RF group also exhibited lower rates of suicidal ideation at both 90 and 180 days.
  • Other PEER subgroups (RF/RNF, RNF/RF, RNF/RNF) showed varied responses, with RF/RF demonstrating the most robust benefits.

Conclusions:

  • Computational analysis of EEG patterns can augment physician decision-making in selecting MDD medications.
  • Personalized, EEG-guided treatment selection shows promise for improving patient outcomes and reducing symptom severity.
  • Further integration of EEG analysis systems into clinical practice may enhance the efficacy of MDD treatment.